Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Capsensixx AGFRA:CPX 88 3-Year EBITDA Growth Rate is 9.60% as of Dec. 2025, which is 92% above its 10-year median of 5.00. GuruFocus rates FRA:CPX with a GF Score™ of 88/100 and a GF Value™ of €28.03 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 510 Asset Management companies, Capsensixx AG ranks worse than 51.96% on this metric.
During the past 12 months, Capsensixx AG's average EBITDA Per Share Growth Rate was 26.70% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 9.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 8.80% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 6.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Capsensixx AG was 22.50% per year. The lowest was -2.20% per year. And the median was 5.00% per year.
Capsensixx AG (FRA:CPX) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Capsensixx AG 3-Year EBITDA Growth Rate Related Terms
FRA:CPX vs BLK, BX, KKR: 3-Year EBITDA Growth Rate Comparison
For the Asset Management subindustry, Capsensixx AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Capsensixx AG 3-Year EBITDA Growth Rate vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Capsensixx AG's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Capsensixx AG's 3-Year EBITDA Growth Rate falls into.
Capsensixx AG 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 9.60% mean?
Capsensixx AG (FRA:CPX) has a 3-Year EBITDA Growth Rate of 9.60% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Capsensixx AG and its competitors. This is 92% above median its historical median of 5.00. According to the industry distribution chart, Capsensixx AG ranks #265 out of 510 companies in the Asset Management industry, placing it in the top 52%.
Is Capsensixx AG's 3-Year EBITDA Growth Rate too high?
Capsensixx AG's current 3-Year EBITDA Growth Rate of 9.60% is 92% above median its 10-year median of 5.00. The Asset Management industry median 3-Year EBITDA Growth Rate is 10.95. Capsensixx AG's value of 9.60% is 12.3% below this industry median. Based on the distribution chart, Capsensixx AG ranks #265 out of 510 companies in the Asset Management industry, which is below the industry midpoint. Overall, Capsensixx AG has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Capsensixx AG's 3-Year EBITDA Growth Rate compare to BLK and BX?
According to the Asset Management industry distribution chart, Capsensixx AG ranks #265 out of 510 companies for 3-Year EBITDA Growth Rate. This places Capsensixx AG in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.95. Capsensixx AG's value of 9.60% is 12.3% below this benchmark. While the company's 10-year median is 5.00 vs. the industry median of 10.95, Capsensixx AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Asset Management company?
The median 3-Year EBITDA Growth Rate among Asset Management companies is 10.95, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Capsensixx AG's current 3-Year EBITDA Growth Rate of 9.60% is 12.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Capsensixx AG and its competitors. For the Asset Management industry, the median 3-Year EBITDA Growth Rate is 10.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Capsensixx AG's current 3-Year EBITDA Growth Rate is 9.60%, which is 92% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Capsensixx AG stock overvalued right now?
Based on GuruFocus' analysis, Capsensixx AG (FRA:CPX) is currently considered Modestly Undervalued. The stock's GF Value™ is €28.03, compared to a current price of €21.00 — trading 25.1% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 9.60%, which is 92% above median its 10-year median of 5.00 and 12.3% below the Asset Management industry median of 10.95. Capsensixx AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Capsensixx AG (FRA:CPX), the current 3-Year EBITDA Growth Rate is 9.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Capsensixx AG (FRA:CPX) Overvalued in 2026?
Based on GuruFocus' analysis, Capsensixx AG stock appears to be undervalued.
The current stock price of €21.00 is trading 25.1% below its estimated GF Value™ of €28.03.
GuruFocus considers Capsensixx AG to be Modestly Undervalued.
Key valuation signals for FRA:CPX:
3-Year EBITDA Growth Rate: 9.60% (92% above median its 10-year median of 5.00)
GF Value™: €28.03 vs. price of €21.00 (25.1% below fair value)
Industry Position: 12.3% below the Asset Management median (#265 of 510)
No single metric tells the full story. See the FRA:CPX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Capsensixx AG is a provider of financial administration as a service. The company is divided into two segments namely Funds management, Administration and Accounting Segment which includes fund management and fund accounting; and Securitisations which provides Advisory services in the field of financial engineering, securitisation and provision of director and administrative services to corporate clients in Luxembourg.
88GF Score
Get the complete analysis for FRA:CPX
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CPX has been successfully added to your 
